Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 11/04/19 | 8-K | Current report filing |
|
6 | |
| 11/01/19 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
35 | |
| 11/01/19 | 8-K | Current report filing |
|
38 | |
| 11/01/19 | 8-K | Current report filing |
|
38 | |
| 11/01/19 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
35 | |
| 10/31/19 | 8-K | Current report filing |
|
7 | |
| 10/25/19 | UPLOAD | SEC-generated letter |
|
1 | |
| 10/23/19 | 8-K | Current report filing |
|
5 | |
| 10/18/19 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
75 | |
| 10/16/19 | 8-K | Current report filing |
|
170 |
